2017
DOI: 10.17691/stm2017.9.4.01
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Cell Genome Editing on the Outcome of Neurotransplantation in Experimental Parkinsonism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 9 publications
(10 reference statements)
0
1
0
Order By: Relevance
“…However, the specific components of bacterial cells that act as active factors and the mechanism of their action remain unknown. Previously, L. fermentum U-21 was shown to act as pharmabiotic, which can reduce pro-inflammatory changes in rat models of Parkinson's disease [48]. Our results suggest that the anti-parkinsonian properties of the L. fermentum U-21 strain are determined, in part, by the ClpL protein and its ability to refold protein aggregates.…”
Section: Discussionmentioning
confidence: 53%
“…However, the specific components of bacterial cells that act as active factors and the mechanism of their action remain unknown. Previously, L. fermentum U-21 was shown to act as pharmabiotic, which can reduce pro-inflammatory changes in rat models of Parkinson's disease [48]. Our results suggest that the anti-parkinsonian properties of the L. fermentum U-21 strain are determined, in part, by the ClpL protein and its ability to refold protein aggregates.…”
Section: Discussionmentioning
confidence: 53%